What are the main strengths of investing in BHVN?

The main strengths of investing in Biohaven Pharmaceutical Holding Company Ltd. include: Strong commitment to ESG principles, Positive impact on society through innovative drug development, Transparent disclosure of ESG performance..

What are the potential drawbacks of investing in BHVN?

Potential drawbacks of investing in Biohaven Pharmaceutical Holding Company Ltd. include: Relatively high financial risk, Limited track record in ESG performance..

What are the key financial metrics for BHVN?

Key financial metrics for Biohaven Pharmaceutical Holding Company Ltd. include: Market Cap: $165.93 billion.

${quote.companyName} (${symbol}) Stock Analysis

Price Chart

Real-time data provided by Alpha Vantage

Financial Metrics

Market Cap

$272.9B

P/E Ratio

N/A

52-Week High

$322.86

52-Week Low

$222.86

Volume

7,520,314

Average Volume

N/A

Dividend Yield

250.00%

Beta

N/A

Key Statistics

Market Cap$272.9B

P/E Ratio (TTM)N/A

Volume7,520,314

Avg VolumeN/A

52-Week High$322.86

52-Week Low$222.86

Dividend Yield250.00%

BetaN/A

ESG Ratings

Overall ESG Score26.0/100

Environmental22.0/100

Social21.0/100

Governance32.0/100

BHVN Inc.

BHVN

$272.86

BHVN Inc. (BHVN)

Price Chart

Financial Metrics

Key Statistics

ESG Ratings